JZ vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 11, 2026

JZ

51.5
AI Score
VS
UTI Wins

UTI

51.7
AI Score

Investment Advisor Scores

JZ

52score
Recommendation
HOLD

UTI

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric JZ UTI Winner
Forward P/E 0 28.8184 Tie
PEG Ratio 0 1.9191 Tie
Revenue Growth 39.8% 7.2% JZ
Earnings Growth -81.2% -78.9% UTI
Tradestie Score 51.5/100 51.7/100 UTI
Profit Margin -28.3% 3.9% UTI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

JZ 1M: -72.5% · 3M: +260.8% UTI 1M: -20.8% · 3M: -50.2%

Current Technical Phase

JZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 35

RSI (14): 34.6 · Price: $0.76

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.7%), weak momentum, RSI 27

RSI (14): 26.9 · Price: $20.31

Fundamentals Snapshot

Metric JZ UTI
Market Cap
Forward P/E 0.0 27.6
Trailing P/E 0.0 34.9
Revenue (TTM)
Revenue Growth 0.4% 0.1%
Gross Margin 0.2% 0.6%
Operating Margin -1.3% 0.0%
EPS 783.10 0.59
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.